The global Comprehensive Solution for Molecular Testing market was valued at US$ 12800 million in 2023 and is anticipated to reach US$ 36810 million by 2030, witnessing a CAGR of 16.3% during the forecast period 2024-2030.
Comprehensive solutions for molecular detection are highly accurate and sensitive technologies for the detection and analysis of biomolecules such as DNA, RNA, proteins and metabolites. These solutions play an important role in fields such as medicine, life sciences, clinical research and bioengineering. Single-cell analysis technologies are rapidly evolving, allowing molecular detection for more refined analysis at the cellular level, helping to understand cellular heterogeneity and discover new therapeutic targets. These technologies are used to analyze and interpret large-scale molecular testing data to discover new biological associations and disease markers.
This report aims to provide a comprehensive presentation of the global market for Comprehensive Solution for Molecular Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Comprehensive Solution for Molecular Testing.
Report Scope
The Comprehensive Solution for Molecular Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Comprehensive Solution for Molecular Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Comprehensive Solution for Molecular Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Roche Diagnostics
Thermo Fisher Scientific
Qiagen
Illumina
Bio-Rad Laboratories
Cepheid
BD
GenMark Diagnostics
Hologic
PerkinElmer
Hanchenguangyi Technology
Shenzhen Guangyu Biotechnology
Hangzhou Leyi Biotechnology
Flashdx
VivaChek Biotech
Segment by Type
Nucleic Acid Amplification Testing
Protein Detection
Metabolite Detection
Others
Segment by Application
Hospital
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Comprehensive Solution for Molecular Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Amplification Testing
1.2.3 Protein Detection
1.2.4 Metabolite Detection
1.2.5 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Comprehensive Solution for Molecular Testing Growth Trends by Region
2.2.1 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Comprehensive Solution for Molecular Testing Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Comprehensive Solution for Molecular Testing Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Dynamics
2.3.1 Comprehensive Solution for Molecular Testing Industry Trends
2.3.2 Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Drivers
2.3.3 Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Challenges
2.3.4 Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Comprehensive Solution for Molecular Testing Players by Revenue
3.1.1 Global Top Comprehensive Solution for Molecular Testing Players by Revenue (2019-2024)
3.1.2 Global Comprehensive Solution for Molecular Testing Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Comprehensive Solution for Molecular Testing Revenue
3.4 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Comprehensive Solution for Molecular Testing Revenue in 2023
3.5 Comprehensive Solution for Molecular Testing Key Players Head office and Area Served
3.6 Key Players Comprehensive Solution for Molecular Testing Product Solution and Service
3.7 Date of Enter into Comprehensive Solution for Molecular Testing Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Comprehensive Solution for Molecular Testing Breakdown Data by Type
4.1 Global Comprehensive Solution for Molecular Testing Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Comprehensive Solution for Molecular Testing Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Comprehensive Solution for Molecular Testing Breakdown Data by Application
5.1 Global Comprehensive Solution for Molecular Testing Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Comprehensive Solution for Molecular Testing Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Comprehensive Solution for Molecular Testing Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Comprehensive Solution for Molecular Testing Introduction
11.1.4 Roche Diagnostics Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Comprehensive Solution for Molecular Testing Introduction
11.3.4 Qiagen Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Comprehensive Solution for Molecular Testing Introduction
11.4.4 Illumina Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Detail
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Comprehensive Solution for Molecular Testing Introduction
11.6.4 Cepheid Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.6.5 Cepheid Recent Development
11.7 BD
11.7.1 BD Company Detail
11.7.2 BD Business Overview
11.7.3 BD Comprehensive Solution for Molecular Testing Introduction
11.7.4 BD Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.7.5 BD Recent Development
11.8 GenMark Diagnostics
11.8.1 GenMark Diagnostics Company Detail
11.8.2 GenMark Diagnostics Business Overview
11.8.3 GenMark Diagnostics Comprehensive Solution for Molecular Testing Introduction
11.8.4 GenMark Diagnostics Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.8.5 GenMark Diagnostics Recent Development
11.9 Hologic
11.9.1 Hologic Company Detail
11.9.2 Hologic Business Overview
11.9.3 Hologic Comprehensive Solution for Molecular Testing Introduction
11.9.4 Hologic Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.9.5 Hologic Recent Development
11.10 PerkinElmer
11.10.1 PerkinElmer Company Detail
11.10.2 PerkinElmer Business Overview
11.10.3 PerkinElmer Comprehensive Solution for Molecular Testing Introduction
11.10.4 PerkinElmer Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.10.5 PerkinElmer Recent Development
11.11 Hanchenguangyi Technology
11.11.1 Hanchenguangyi Technology Company Detail
11.11.2 Hanchenguangyi Technology Business Overview
11.11.3 Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Introduction
11.11.4 Hanchenguangyi Technology Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.11.5 Hanchenguangyi Technology Recent Development
11.12 Shenzhen Guangyu Biotechnology
11.12.1 Shenzhen Guangyu Biotechnology Company Detail
11.12.2 Shenzhen Guangyu Biotechnology Business Overview
11.12.3 Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Introduction
11.12.4 Shenzhen Guangyu Biotechnology Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.12.5 Shenzhen Guangyu Biotechnology Recent Development
11.13 Hangzhou Leyi Biotechnology
11.13.1 Hangzhou Leyi Biotechnology Company Detail
11.13.2 Hangzhou Leyi Biotechnology Business Overview
11.13.3 Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Introduction
11.13.4 Hangzhou Leyi Biotechnology Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.13.5 Hangzhou Leyi Biotechnology Recent Development
11.14 Flashdx
11.14.1 Flashdx Company Detail
11.14.2 Flashdx Business Overview
11.14.3 Flashdx Comprehensive Solution for Molecular Testing Introduction
11.14.4 Flashdx Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.14.5 Flashdx Recent Development
11.15 VivaChek Biotech
11.15.1 VivaChek Biotech Company Detail
11.15.2 VivaChek Biotech Business Overview
11.15.3 VivaChek Biotech Comprehensive Solution for Molecular Testing Introduction
11.15.4 VivaChek Biotech Revenue in Comprehensive Solution for Molecular Testing Business (2019-2024)
11.15.5 VivaChek Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche Diagnostics
Thermo Fisher Scientific
Qiagen
Illumina
Bio-Rad Laboratories
Cepheid
BD
GenMark Diagnostics
Hologic
PerkinElmer
Hanchenguangyi Technology
Shenzhen Guangyu Biotechnology
Hangzhou Leyi Biotechnology
Flashdx
VivaChek Biotech
Ìý
Ìý
*If Applicable.